Concepedia

Andreu Òdena

AÒ

Statistics

Publications

6

Citations

227

H-Index

6

Active since

2020

Affiliations

Vall d'Hebron Hospital Universitari(Current)

Universitat Autònoma de Barcelona

Vall d'Hebron Institute of Oncology

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer

Institut Català d'Oncologia

Andreu Òdena is an author at Vall d'Hebron Hospital Universitari specializing in oncology, molecular oncology, and pharmacology.

ORCID

Publications per year

2020–2025

6

Publications

6

High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer

Marta Palafox, Laia Monserrat, Meritxell Bellet et al. · Nature Communications · 2022 · 120 citations · Full text

, , +16

Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts

Albert Gris‐Oliver, Marta Palafox, Laia Monserrat et al. · Clinical Cancer Research · 2020 · 41 citations · Full text

, , +17

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

Fara Brasó‐Maristany, J.M. Ferrero-Cafiero, Claudette Falato et al. · Nature Communications · 2024 · 23 citations · Full text

, , +16

Harnessing STING Signaling and Natural Killer Cells Overcomes PARP Inhibitor Resistance in Homologous Recombination–Deficient Breast Cancer

Flaminia Pedretti, Mohmed Abdalfttah, Benedetta Pellegrino et al. · Cancer Research · 2025 · 16 citations · Full text

, , +17

Enhancing CHO cell productivity through a dual selection system using Aspg and Gs in glutamine free medium

Tae Kwang Ha, Andreu Òdena, Karen Julie la Cour Karottki et al. · Biotechnology and Bioengineering · 2022 · 15 citations

, , +15

1–5 of 6